These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Shifting from the single to the multitarget paradigm in drug discovery. Medina-Franco JL; Giulianotti MA; Welmaker GS; Houghten RA Drug Discov Today; 2013 May; 18(9-10):495-501. PubMed ID: 23340113 [TBL] [Abstract][Full Text] [Related]
25. Scanning structure-activity relationships with structure-activity similarity and related maps: from consensus activity cliffs to selectivity switches. Medina-Franco JL J Chem Inf Model; 2012 Oct; 52(10):2485-93. PubMed ID: 22989212 [TBL] [Abstract][Full Text] [Related]
26. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. Duffy BC; Zhu L; Decornez H; Kitchen DB Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785 [TBL] [Abstract][Full Text] [Related]
27. CASE plots for the chemotype-based activity and selectivity analysis: a CASE study of cyclooxygenase inhibitors. Pérez-Villanueva J; Medina-Franco JL; Méndez-Lucio O; Yoo J; Soria-Arteche O; Izquierdo T; Lozada MC; Castillo R Chem Biol Drug Des; 2012 Nov; 80(5):752-62. PubMed ID: 22883137 [TBL] [Abstract][Full Text] [Related]
28. How similar are those molecules after all? Use two descriptors and you will have three different answers. Bender A Expert Opin Drug Discov; 2010 Dec; 5(12):1141-51. PubMed ID: 22822717 [TBL] [Abstract][Full Text] [Related]
29. SAR matrices: automated extraction of information-rich SAR tables from large compound data sets. Wassermann AM; Haebel P; Weskamp N; Bajorath J J Chem Inf Model; 2012 Jul; 52(7):1769-76. PubMed ID: 22657271 [TBL] [Abstract][Full Text] [Related]
37. Single R-Group Polymorphisms (SRPs) and R-cliffs: an intuitive framework for analyzing and visualizing activity cliffs in a single analog series. Agrafiotis DK; Wiener JJ; Skalkin A; Kolpak J J Chem Inf Model; 2011 May; 51(5):1122-31. PubMed ID: 21504183 [TBL] [Abstract][Full Text] [Related]
38. Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Pérez-Villanueva J; Santos R; Hernández-Campos A; Giulianotti MA; Castillo R; Medina-Franco JL Bioorg Med Chem; 2010 Nov; 18(21):7380-91. PubMed ID: 20888242 [TBL] [Abstract][Full Text] [Related]
39. Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. Sastry M; Lowrie JF; Dixon SL; Sherman W J Chem Inf Model; 2010 May; 50(5):771-84. PubMed ID: 20450209 [TBL] [Abstract][Full Text] [Related]